Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03839628 · ClinicalTrials.gov registry record · NA
Translational Control of Anabolic Resistance in Aging Muscle
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03839628: Completed NA study, sponsored by University of Utah.
NCT03839628 is a NA study that has completed, run by University of Utah. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03839628, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is an interventional study enrolling older individuals aged 60-85y to observe changes during physical inactivity. This study is investigating the relation between short-term physical inactivity and the impact of muscle health and function. The enrollment goal is 8 participants. The study will occur over the course of a month where participants will undergo testing before and after a reduction in physically activity levels. There will be a screening event collecting baseline data, two body composition scans, muscle function and oral glucose tolerance tests and a metabolic study before and after a 2-week period of inactivity. Each metabolic study will entail three-muscle biopsies: one before and 2 after the ingestion of leucine.
Primary Outcome
Change in lean mass
Interventions
- OTHER Reduced Physical Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2019-12-17 |
| Phase | NA |
What the finished NCT03839628 record still lists
NCT03839628 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Reduced Physical Activity is the first listed.
NCT03839628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03839628 about?
NCT03839628 is a clinical study titled "Translational Control of Anabolic Resistance in Aging Muscle". This is an interventional study enrolling older individuals aged 60-85y to observe changes during physical inactivity. This study is investigating the relation between short-term physical inactivity and the impact of muscle health and function. The enrollment goal is 8 participants. The study will o...
What is the current status of trial NCT03839628?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-03-05. Estimated completion is 2019-12-17.
What interventions are being tested in trial NCT03839628?
The interventions under investigation include: Reduced Physical Activity (OTHER).
Who is sponsoring clinical trial NCT03839628?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03839628's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI